FT Vest U.S. Equity Equal Weight Buffer ETF - March (RSMR)
Live price chart, market sentiment, and community perspectives for FT Vest U.S. Equity Equal Weight Buffer ETF - March (AMEX: RSMR).
Live price chart, market sentiment, and community perspectives for FT Vest U.S. Equity Equal Weight Buffer ETF - March (AMEX: RSMR).
On our desk, watching the 50-day moving average hover around $23.56 while the 200-day sits at $22.89 gives us a clear look at RSMR's steady technical trajectory. Even with an expense ratio of 0.85% and modest daily volumes averaging around 3,250 shares, the defined-outcome mechanism provides a solid defensive layer for large cap blend equity exposure through March 2027.
Analyzing the recent Q2 regulatory filings, we note that 13 hedge funds and large institutions hold roughly $6.36 million in assets, representing 59.73% ownership. Although total institutional ownership decreased by about 5.5%, the presence of new position openings shows selective ongoing interest in its 10% downside buffer strategy.
When evaluating the target outcome period running from March 23, 2026, through March 19, 2027, the fund's heavy reliance on FLexible EXchange Options referencing the Invesco SandP 500 Equal Weight ETF Trust is critical. The predetermined upside cap of 17.80% effectively limits runaway bull market participation in exchange for principal defense against the initial 10% drop.
Short interest metrics for RSMR have shown wild swings recently, dropping 71.8% in mid-June down to 3,414 shares before jumping 87.6% by mid-July to reach 6,406 shares. With a days-to-cover ratio climbing to 11.5 days based on lower daily volumes, market makers must carefully navigate these shifts in localized bearish sentiment.
Reviewing the fund's advisory and servicing framework, First Trust Advisors L.P. as investment advisor and Vest Financial as sub-advisor maintain a consistent target outcome architecture. With total net assets hovering near $10.82 million and 450,002 shares outstanding, liquidity profiling remains a key constraint for larger institutional reallocations.
Explore plasma cleansing, somatic organ swaps, and BCI.